Clinical Review#: State of the art for genetic testing of infertile men
- PMID: 20089613
- DOI: 10.1210/jc.2009-1925
Clinical Review#: State of the art for genetic testing of infertile men
Abstract
Intracytoplasmic sperm injection (ICSI) now provides fertility in many cases of severe idiopathic spermatogenic failure and obstructive azoospermia. Genetic causes must be sought by systematic evaluation of infertile men and affected couples informed about the implications of such diagnoses for assisted reproductive technology outcome and their potential offspring. This review discusses established and emerging genetic disorders related to fertility practice. Chromosomal anomalies are found in about 7% men with idiopathic spermatogenic failure, predominantly numerical/structural in azoospermic men and translocations/inversions in oligospermic men. Routine karyotyping of men with sperm densities less than 10 million/ml, even in the absence of other clinical presentations, is recommended because infertility is associated with higher rates of aneuploidy in ejaculated or testicular sperm and increased chromosomal defects in ICSI offspring. The long arm of the Y chromosome microdeletions are the most common recognized genetic cause of infertility and are found in about 4% men with sperm densities less than 5 million/ml. Routine testing using strict quality assurance procedures is recommended. Azoospermia factor (AZF)-c deletions, the most common form of the long arm of the Y chromosome microdeletions, are usually associated with low levels of sperm in the ejaculate or in testis biopsies, whereas men with AZFa or AZFb+c deletions usually produce no testicular sperm. When AZF-deleted sperm are available and used for ICSI, fertility defects in male offspring seem inevitable. Bilateral congenital absence of the vas is associated with heterozygosity for cystic fibrosis transmembrane receptor mutations making routine gene screening and genetic counseling of the couple essential. Testing for less common genetic associations/defects linked with different reproductive dysfunction may be applicable to specific patients but have not entered routine practice.
Similar articles
-
First study of microdeletions in the Y chromosome of Algerian infertile men with idiopathic oligo- or azoospermia.Urol Int. 2013;90(4):455-9. doi: 10.1159/000347046. Epub 2013 Mar 16. Urol Int. 2013. PMID: 23548818
-
Genetic markers of male infertility: Y chromosome microdeletions and cystic fibrosis transmembrane conductance gene mutations.Croat Med J. 2001 Aug;42(4):416-20. Croat Med J. 2001. PMID: 11471192 Review.
-
Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy.J Clin Endocrinol Metab. 2007 Mar;92(3):762-70. doi: 10.1210/jc.2006-1981. Epub 2007 Jan 9. J Clin Endocrinol Metab. 2007. PMID: 17213277
-
Genetics of human male infertility.Singapore Med J. 2009 Apr;50(4):336-47. Singapore Med J. 2009. PMID: 19421675 Review.
-
Clinical review 100: Evaluation and treatment of the infertile couple.J Clin Endocrinol Metab. 1998 Dec;83(12):4177-88. doi: 10.1210/jcem.83.12.5296. J Clin Endocrinol Metab. 1998. PMID: 9851748 Review.
Cited by
-
Fidgetin-like1 is a strong candidate for a dynamic impairment of male meiosis leading to reduced testis weight in mice.PLoS One. 2011;6(11):e27582. doi: 10.1371/journal.pone.0027582. Epub 2011 Nov 16. PLoS One. 2011. PMID: 22110678 Free PMC article.
-
The infertile individual analysis based on whole-exome sequencing in chinese multi-ethnic groups.Genes Genomics. 2023 Apr;45(4):531-542. doi: 10.1007/s13258-022-01307-z. Epub 2022 Sep 17. Genes Genomics. 2023. PMID: 36115009
-
Guideline-based management of male infertility: Why do we need it?Indian J Urol. 2011 Jan;27(1):49-57. doi: 10.4103/0970-1591.78426. Indian J Urol. 2011. PMID: 21716890 Free PMC article.
-
Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility.Physiol Rev. 2016 Jan;96(1):55-97. doi: 10.1152/physrev.00017.2015. Physiol Rev. 2016. PMID: 26582516 Free PMC article. Review.
-
RBM5 is a male germ cell splicing factor and is required for spermatid differentiation and male fertility.PLoS Genet. 2013;9(7):e1003628. doi: 10.1371/journal.pgen.1003628. Epub 2013 Jul 25. PLoS Genet. 2013. PMID: 23935508 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical